# US 8,278,037 B2 · N-acetylgalactosamine transferases and nucleic acids encoding the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,037 B2
- Document ID: US8278037B2
- Status: Granted
- Kind: B2
- Application number: 12/353,385
- Filed: 2009-01-14
- Published: 2009-08-06
- Granted: 2012-10-02
- Earliest claimed: 2002-08-14
- Assignees: National Institute of Advanced Industrial Science and Technology
- Inventors: Hisashi Narimatsu; Masanori Gotoh; Takashi Sato
- Web page: https://patentgrep.com/patent/US8278037B2

## CPC

- C12N 9/1051: {Hexosyltransferases (2.4.1)}
- G01N 33/5758: {involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

An enzyme which transfers N-acetylgalactosamine to N-acetylglucosamine via a β1-4 linkage was isolated and the structure of its gene was explained. This led to the production of said enzyme or the like by genetic engineering techniques, the production of oligosaccharides using said enzyme, and the diagnosis of diseases on the basis of said gene or the like. The present invention uses a protein having the amino acid sequence shown in SEQ ID NO: 1, 3, 26 or 27 in the Sequence Listing or a variant of said amino acid sequence wherein one or more acids are substituted or deleted, or one or more acids are inserted or added and having the activity of transferring N-acetylgalactosamine (GalNAc) to N-acetylglucosamine serving as a substrate via a β1-4 linkage and nucleic acids encoding said protein.

## Claims

### Claim 1

An isolated nucleic acid which encodes a protein having the amino acid sequence shown in SEQ ID NO:1, or a protein having an identity at least 95% or more to the amino acid sequence shown in SEQ ID NO:1 and having the activity of transferring N-acetylgalactosamine to N-acetylglucosamine via a β1-4 linkage.

### Claim 2

An isolated nucleic acid which encodes a variant of a protein having the amino acid sequence shown in SEQ ID NO:1 and having the activity of transferring N-acetylgalactosamine to N-acetylglucosamine via a β1-4 linkage, wherein the nucleic acid hybridizes with a nucleic acid having the nucleotide sequence shown in SEQ ID NO: 2 under high stringent conditions comprising hybridization conditions of 50% formamide, 2×SSC, 50° C. and washing conditions of 0.2×SSC, 0.1% SDS, 68° C., or the nucleic acid has an identity at least 95% or more to the nucleic acid sequence shown in SEQ ID NO:2.

### Claim 3 (depends on 2)

The isolated nucleic acid of claim 2 having a nucleotide sequence comprising nucleotides 1-3120 of SEQ ID NO: 2.

### Claim 4 (depends on 1)

A recombinant vector containing the nucleic acid of claim 1 and being capable of expressing said nucleic acid in a host cell.

### Claim 5 (depends on 4)

An isolated host cell transformed with the recombinant vector of claim 4.

### Claim 6 (depends on 1, 2)

An assay kit comprising a nucleic acid of claim 1 or 2, and assay instructions.
